Home › Funds › Tejara Capital Ltd › MRVI

Tejara Capital Ltd position in MRVI

MARAVAI LIFESCIENCES HLDGS I · Health Care

Tejara Capital Ltd reported holding 1,595,345 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 4.09% of its reported portfolio and ranking #5 among its reported holdings. Tejara Capital Ltd has disclosed MRVI holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.60M sh
Reported value held$9.95M
Portfolio Weight4.09%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tejara Capital Ltd's MRVI position evolved

Tejara Capital Ltd first disclosed a stake in MRVI in Q1 2025 at 542,549 shares (US$1.2M). The position peaked in Q2 2026 at 1,595,345 shares, worth US$10.0M. Across 6 filings, Tejara Capital Ltd increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,595,345 shares valued at US$10.0M — a reduction of -1,899,842 shares quarter over quarter.. Notable position changes include a 258% increase in Q2 2025 (shares rose 19% over the following quarter), a 26% increase in Q3 2025 (shares rose 13% over the following quarter), a 54% trim in Q2 2026 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 542.55K $1.20M New
Q2 2025 1.94M $4.68M Add
Q3 2025 2.45M $7.04M Add
Q4 2025 3.02M $9.82M Add
Q1 2026 3.50M $9.89M Add
Q2 2026 1.60M $9.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRVI and 13F data

MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 35 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$125.7M), BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRVI

All MRVI fund holders →

FAQ

How long has Tejara Capital Ltd held MRVI?

Tejara Capital Ltd has disclosed MRVI holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Tejara Capital Ltd's current position in MRVI?

As of Q2 2026, Tejara Capital Ltd holds 1.60M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $9.95M, representing 4.09% of its reported portfolio and ranking #5.

Has Tejara Capital Ltd been buying or selling MRVI?

In the latest 13F filing (Q2 2026), Tejara Capital Ltd reduced its position in MRVI. The position peaked in Q2 2026 at 1.60M shares.

Which other funds hold MRVI?

Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, 12 West Capital Management LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.